 |
Recombinant P-selectin glycoprotein ligand-immunoglobulin Ig |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of ischemia reperfusion injury in all solid organ transplants |
| USA Market Approval | USA |
| USA Designation Date | 2007-07-26 00:00:00 |
| Sponsor | Y's Therapeutics, Inc.;1539 Granger Way;Redwood City, California, 94061 |
